GE HealthCare has partnered with radiation therapy company Elekta to develop new software to improve clinicians experience and enable greater precision treatment.
Elekta will use GE HealthCare’s MIM Software imaging management platform, which GE HealthCare acquired earlier this month. MIM’s auto contouring and treatment management platform will allow Elekta to develop radiation oncology...
Scottish sensor technology startup Novosound secured a patent for its ultrasound instrumentation system, the Slanj digital platform, which is targeted at the medical and wearable-device market.
Novosound produces a wearable, WiFi-enabled ultrasound device that uses gel-free, high-resolution sensors to solve issues associated with traditional ultrasound technology.
The patent gives Novosound...
GE HealthCare announced that its Brazil-based partner Ionic Health received FDA 510(k) clearance for its nCommand Lite, which provides diagnostic imaging centers with real-time scanning, remote guidance and operational support, and the ability to view/review images remotely.
Ionic’s software interacts with equipment like a local technician, enabling remote operation of MRI, CT and PET scans with...
Israeli imaging company Nanox announced Monday it completed its merger with Zebra Medical Vision, now rebranded as Nanox.AI, for approximately $110 million in stock, with the ability to earn an additional $84 million in stock based on performance.
Nanox also wrapped up the acquisition of teleradiology provider USARAD Holdings and its affiliated company MDWEB, which offers a marketplace for...
Israeli imaging startup Nanox has landed FDA clearance for its single-source digital X-ray Nanox.ARC, the company announced today. Nanox came on the imaging scene pitching to lower costs and sell its system via a price-per-scan model.
The company’s system combines an in-hospital scanning device with a companion cloud software tool. The X-ray device, which just landed the single-source clearance,...
Put your X-ray where your mouth is. After fielding accusations of fraud that temporarily damaged the value of its stock, digital X-ray-imaging company Nanox gave a highly publicized live (but virtual) demonstration of its imaging technology at the Radiology Society of North America's annual meeting.
The demo – a recording of which Nanox said will be available to the public later today from the...
Israeli "digital X-ray" company Nanox is fielding increased scrutiny and a sizable hit to its share prices following the publication of a scathing report and commentary that referred to the company as "Theranos 2.0."
The criticism was posted yesterday by activist short seller Andrew Left's Citron Research, an online stock analysis and commentary blog that has focused on identifying overpriced or...
British startup iAbra has launched a screening device which can deliver COVID-19 test results in 20 seconds.
After a successful three-week trial at London’s Heathrow Airport, CEO John Holland-Kaye urged the UK government to fast-track the Virolens system, which he says is quicker and cheaper than the currently used polymerase chain reaction (PCR) tests.
The technology, which is about to undergo...
Israeli "digital X-ray" startup Nanox filed a Form F-1 with the SEC on Friday that outlines plans to raise $125 million in an IPO.
The company has applied to list its shares on the Nasdaq exchange as "NNOX," and according to a representative has entered its quiet period prior to the IPO.
Nanox, which has raised $110 million from investors since November 2019, is building a two-part offering...
Israeli "digital X-ray" startup Nanox has secured another $59 million from unnamed "global investors."
The company now pegs its round total at $110 million, after combining today's news with investments announced since November of 2019. Contributors to those incremental raises included Foxconn, Fujifilm and SK Telecom.
WHAT IT DOES
The Israeli company is developing a two-pronged offering...
_3.jpg?itok=ZRQxDHm7 "Businesspeople shaking hands")
_0_0.jpg?itok=hp4VKSAi "The Virolens system has undergone a successful trial at London’s Heathrow Airport.")
